As of 2025-10-16, the Relative Valuation of Ironwood Pharmaceuticals Inc (IRWD) is 1.13 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.61 USD, the upside of Ironwood Pharmaceuticals Inc based on Relative Valuation is -29.6%.
The range of the Relative Valuation is (0.53) - 3.74 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 15.8x | 13.7x |
| Forward P/E multiples | 12.4x - 17.3x | 13.6x |
| Fair Price | (0.53) - 3.74 | 1.13 |
| Upside | -133.0% - 132.3% | -29.6% |
| Date | P/E |
| 2025-10-15 | -33.17 |
| 2025-10-14 | -30.49 |
| 2025-10-13 | -30.49 |
| 2025-10-10 | -32.65 |
| 2025-10-09 | -36.46 |
| 2025-10-08 | -32.55 |
| 2025-10-07 | -31.31 |
| 2025-10-06 | -30.49 |
| 2025-10-03 | -31.93 |
| 2025-10-02 | -33.17 |
| 2025-10-01 | -30.08 |
| 2025-09-30 | -26.99 |
| 2025-09-29 | -29.25 |
| 2025-09-26 | -28.63 |
| 2025-09-25 | -26.16 |
| 2025-09-24 | -28.22 |
| 2025-09-23 | -28.63 |
| 2025-09-22 | -29.66 |
| 2025-09-19 | -29.05 |
| 2025-09-18 | -30.08 |
| 2025-09-17 | -26.37 |
| 2025-09-16 | -26.78 |
| 2025-09-15 | -26.37 |
| 2025-09-12 | -26.99 |
| 2025-09-11 | -25.54 |
| 2025-09-10 | -23.69 |
| 2025-09-09 | -22.87 |
| 2025-09-08 | -23.28 |
| 2025-09-05 | -23.79 |
| 2025-09-04 | -22.66 |
| 2025-09-03 | -25.54 |
| 2025-09-02 | -26.99 |
| 2025-08-29 | -27.19 |
| 2025-08-28 | -27.19 |
| 2025-08-27 | -25.96 |
| 2025-08-26 | -26.16 |
| 2025-08-25 | -26.16 |
| 2025-08-22 | -26.16 |
| 2025-08-21 | -24.31 |
| 2025-08-20 | -22.66 |
| 2025-08-19 | -22.04 |
| 2025-08-18 | -23.28 |
| 2025-08-15 | -21.22 |
| 2025-08-14 | -22.04 |
| 2025-08-13 | -22.45 |
| 2025-08-12 | -20.24 |
| 2025-08-11 | -17.23 |
| 2025-08-08 | -18.48 |
| 2025-08-07 | -18.13 |
| 2025-08-06 | -16.58 |